Barclays’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $89.8M | Buy |
412,700
+313,900
| +318% | +$69.6M | 0.02% | 527 |
|
|
2025
Q4 | $22.6M | Hold |
98,800
| – | – | 0.01% | 1195 |
|
|
2025
Q3 | $22.9M | Sell |
98,800
-16,000
| -14% | -$3.26M | 0.01% | 1160 |
|
|
2025
Q2 | $21.3M | Sell |
114,800
-500
| -0.4% | -$92.9K | ﹤0.01% | 1100 |
|
|
2025
Q1 | $24.2M | Sell |
115,300
-46,900
| -29% | -$9.12M | 0.01% | 937 |
|
|
2024
Q4 | $28.8M | Sell |
162,200
-75,800
| -32% | -$13.9M | 0.01% | 918 |
|
|
2024
Q3 | $47M | Buy |
+238,000
| New | +$44.4M | 0.01% | 696 |
|
|
2024
Q2 | – | Sell |
-206,200
| Closed | -$37.5M | – | 4812 |
|
|
2024
Q1 | $37.5M | Sell |
206,200
-164,400
| -44% | -$28.3M | 0.01% | 722 |
|
|
2023
Q4 | $57.4M | Buy |
+370,600
| New | +$54M | 0.02% | 607 |
|
|
2023
Q2 | – | Sell |
-422,800
| Closed | -$67.4M | – | 4502 |
|
|
2023
Q1 | $67.4M | Buy |
422,800
+143,600
| +51% | +$22M | 0.03% | 348 |
|
|
2022
Q4 | $45.1M | Hold |
279,200
| – | – | 0.02% | 541 |
|
|
2022
Q3 | $37.5M | Buy |
279,200
+76,400
| +38% | +$11M | 0.04% | 397 |
|
|
2022
Q2 | $31.1M | Buy |
202,800
+37,200
| +22% | +$5.68M | 0.02% | 543 |
|
|
2022
Q1 | $26.8M | Buy |
165,600
+137,900
| +498% | +$20M | 0.02% | 589 |
|
|
2021
Q4 | $3.75M | Sell |
27,700
-20,000
| -42% | -$2.36M | ﹤0.01% | 1921 |
|
|
2021
Q3 | $5.15M | Sell |
47,700
-386,800
| -89% | -$44.2M | ﹤0.01% | 1623 |
|
|
2021
Q2 | $48.9M | Buy |
434,500
+432,000
| +17,280% | +$48.7M | 0.02% | 530 |
|
|
2021
Q1 | $271K | Sell |
2,500
-1,360,228
| -100% | -$145M | ﹤0.01% | 3558 |
|
|
2020
Q4 | $146M | Buy |
1,362,728
+450,000
| +49% | +$43.2M | 0.08% | 195 |
|
|
2020
Q3 | $79.9M | Sell |
912,728
-13,974
| -2% | -$1.32M | 0.05% | 274 |
|
|
2020
Q2 | $91M | Sell |
926,702
-139,098
| -13% | -$12.2M | 0.07% | 212 |
|
|
2020
Q1 | $81.2M | Buy |
1,065,800
+447,800
| +72% | +$38.1M | 0.06% | 199 |
|
|
2019
Q4 | $54.7M | Buy |
618,000
+195,000
| +46% | +$16.2M | 0.03% | 474 |
|
|
2019
Q3 | $32M | Sell |
423,000
-125,000
| -23% | -$8.57M | 0.02% | 637 |
|
|
2019
Q2 | $39.9M | Buy |
548,000
+300,200
| +121% | +$23.6M | 0.02% | 567 |
|
|
2019
Q1 | $20M | Sell |
247,800
-49,300
| -17% | -$4.03M | 0.01% | 856 |
|
|
2018
Q4 | $27.4M | Sell |
297,100
-10,300
| -3% | -$906K | 0.02% | 608 |
|
|
2018
Q3 | $29.1M | Sell |
307,400
-72,700
| -19% | -$6.89M | 0.02% | 662 |
|
|
2018
Q2 | $35.2M | Buy |
380,100
+2,900
| +0.8% | +$283K | 0.03% | 501 |
|
|
2018
Q1 | $35.7M | Buy |
377,200
+124,800
| +49% | +$13.7M | 0.03% | 563 |
|
|
2017
Q4 | $24.4M | Buy |
252,400
+118,100
| +88% | +$11.1M | 0.02% | 703 |
|
|
2017
Q3 | $11.9M | Sell |
134,300
-33,500
| -20% | -$2.55M | 0.01% | 940 |
|
|
2017
Q2 | $12.2M | Sell |
167,800
-579,800
| -78% | -$39M | 0.01% | 856 |
|
|
2017
Q1 | $48.7M | Buy |
747,600
+440,224
| +143% | +$27.7M | 0.05% | 256 |
|
|
2016
Q4 | $19.2M | Buy |
307,376
+43,700
| +17% | +$2.67M | 0.02% | 617 |
|
|
2016
Q3 | $16.6M | Sell |
263,676
-316,300
| -55% | -$20.5M | 0.02% | 625 |
|
|
2016
Q2 | $35.9M | Buy |
579,976
+342,400
| +144% | +$20.9M | 0.05% | 330 |
|
|
2016
Q1 | $13.5M | Sell |
237,576
-793,038
| -77% | -$44.2M | 0.02% | 625 |
|
|
2015
Q4 | $60.8M | Sell |
1,030,614
-176,170
| -15% | -$10.1M | 0.07% | 233 |
|
|
2015
Q3 | $65.2M | Buy |
1,206,784
+426,402
| +55% | +$27.8M | 0.08% | 214 |
|
|
2015
Q2 | $52.3M | Sell |
780,382
-919,118
| -54% | -$60M | 0.06% | 282 |
|
|
2015
Q1 | $98.6M | Buy |
1,699,500
+591,800
| +53% | +$35.8M | 0.11% | 160 |
|
|
2014
Q4 | $72M | Sell |
1,107,700
-360,700
| -25% | -$22.7M | 0.07% | 233 |
|
|
2014
Q3 | $83.7M | Buy |
1,468,400
+1,341,200
| +1,054% | +$74.5M | 0.08% | 196 |
|
|
2014
Q2 | $7.12M | Sell |
127,200
-87,300
| -41% | -$4.58M | 0.01% | 1423 |
|
|
2014
Q1 | $10.9M | Buy |
214,500
+21,400
| +11% | +$1.08M | 0.01% | 1080 |
|
|
2013
Q4 | $10M | Buy |
193,100
+119,600
| +163% | +$5.88M | 0.01% | 1252 |
|
|
2013
Q3 | $3.23M | Sell |
73,500
-50,800
| -41% | -$2.25M | ﹤0.01% | 2091 |
|
|
2013
Q2 | $5.14M | Buy |
+124,300
| New | +$5.44M | 0.01% | 1607 |
|
Other funds holding ABBV
VCM
VPM
Barclays's ABBV Position: Q1 2026 in Review
Barclays increased its AbbVie (ABBV) stake by 15% in Q1 2026, buying an estimated $162M and bringing the position to 5,571,610 shares worth $1.21B. The position accounts for 0.29% of the portfolio, ranked #46.
Barclays first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Barclays held 5,571,610 shares of AbbVie worth $1.21B as of Q1 2026.
- Barclays bought 731,465 AbbVie shares in Q1 2026, an estimated $162M.
- AbbVie made up 0.29% of Barclays's portfolio in Q1 2026, its #46 holding.
- Barclays first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.